Label: VERRUSTAT WART REMOVER- salicylic acid liquid

  • NDC Code(s): 44577-020-15
  • Packager: Clinical Therapeutic Solutions
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated November 5, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Salicylic Acid 17%

  • Purpose

    wart treatment

  • Uses:

    • For the removal of common and plantar warts. The common wart has a rough 'cauliflower-like' appearance. The plantar wart exists only on the bottom of the foot  and interrupts the footprint pattern.
  • Warnings

    For external use only. Do not use this product on irritated skin, on any area that is infected or reddened, if you are a diabetic, or if you have poor blood circulation. If discomfort persists, see your doctor. Do not use on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. Flammable. Keep away from fire or flame. Cap bottle tightly and store at room temperature away from heat. If product gets into the eye, flush with water for 15 minutes. Avoid inhaling vapors.


  • Directions

    • wash or soak the affected area and dry thoroughly
    • apply wart remover liquid, with enclosed applicator
    • reapply subsequent applications over existing application
    • repeat the procedure once or twice daily, until wart is completely removed, for up to 12 weeks
  • Other Information

    • Store between 20 degrees to 30 degrees C (68 degrees to 86 degrees F)


  • Other Ingredients

    Butyl Acetate, Ethyl Acetate, Isopropyl Alcohol, Methylsulfonylmethane (MSM), Nitrocellulose, Retinyl Palmitate, SD-Alcohol 40B

  • VerruStat Liquid Wart Remover 15ml (44577-020-15)

    VerruStatLiquidBottle
    VerruStatLiquidBox


  • INGREDIENTS AND APPEARANCE
    VERRUSTAT WART REMOVER 
    salicylic acid liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:44577-020
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID170 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    BUTYL ACETATE (UNII: 464P5N1905)  
    ETHYL ACETATE (UNII: 76845O8NMZ)  
    ISOPROPYL ALCOHOL (UNII: ND2M416302)  
    DIMETHYL SULFONE (UNII: 9H4PO4Z4FT)  
    PYROXYLIN (UNII: KYR8BR2X6O)  
    VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
    ALCOHOL (UNII: 3K9958V90M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:44577-020-151 in 1 BOX02/06/2017
    115 mL in 1 BOTTLE, WITH APPLICATOR; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02810/16/2013
    Labeler - Clinical Therapeutic Solutions (078402750)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!